05/06/2026
Results from CFP-funded research on medication optimization for heart-failure patients has captured the attention of the B.C. government.
The pilot randomized control trial (RCT), led by Ricky Turgeon and his research team at the University of British Columbia and funded by CFP’s Innovation Fund, found that even when more than 90% of patients were on guideline-recommended therapies, most were not at target doses.
Results from CFP-funded research on medication optimization for heart-failure patients has captured the attention of the B.C. government.